Spatially Sussing Out the TME, No Tissue Needed.

Machine learning reveals conserved spatial ecotypes in tumor microenvironments across cancers, potentially predicting immune checkpoint therapy response.

• Why it matters: Understanding the tumor microenvironment (TME) is crucial for improving immunotherapy outcomes, but current methods are invasive and limited in scope. Identifying noninvasive ways to monitor TME characteristics can enhance personalized treatment strategies.
• What they did: Researchers applied machine learning to analyze tumor samples, discovering distinct spatial ecotypes conserved across multiple cancer types, and demonstrated these ecotypes can be identified via methylation profiling.
• The result: This approach enables noninvasive monitoring of TME via liquid biopsy, offering a promising tool for predicting therapy response and guiding treatment decisions without tissue sampling.